Myers Bigel has been recognized as one of the leading private practice patent firms in the world by IAM Patent 1000 2015 – The World’s Leading Patent Professionals.
Additionally, three attorneys at the firm – Mitch Bigel, Alice Bonnen, and Jim Cannon – were highlighted in the global resource for best-in-class patent prosecution, licensing and litigation practitioners.
“Our talented legal team continues to produce quality work that speaks for itself, garnering attention of leading industry organizations and publications like IAM Patent 1000,” David Purks, managing partner, said.
The publication lauded Myers Bigel for its prowess at protecting electronic and computer-related technologies, and noted the firm’s “strong core of prosecution experts who you can trust to do a good job and provide solid counsel.” Myers Bigel was the only independent patent law firm listed for North Carolina.
Alice Bonnen, head of the firm’s ChemBio group, was hailed for her unstinting focus on quality while fellow IAM Patent 1000 veteran Mitch Bigel received compliments for being, “brilliant at engaging with examiners in a way that helps clients to obtain the patent rights that will be most useful to their business.”
This is the first year Jim Cannon has made the list, recognized for his background encompassing both biology and mechanical engineering which contributes to a comfort level on a range of different technologies.
Myers Bigel attorneys are registered to practice before the United States Patent and Trademark Office, and boast significant prior real-world industry experience that allows them to successfully interact with and counsel both the technical staff and the management of clients.
The firm emphasizes patent procurement and litigation, with practice areas divided along technology lines: Biotechnology, Chemical, Electronics/Computer and Mechanical, in addition to Trademark and Litigation groups.
The IAM Patent 1000 rankings are based on around 1,500 interviews with both private practice and in-house professionals. The inclusion of Bonnen, Cannon and Bigel in the current edition is based exclusively on the findings of the IAM research team reviewing statistics over the past three years, reflecting an accurate representation of the highest quality patents.